28035718|t|THSD7A expression in human cancer
28035718|a|We recently described a case of a Thrombospondin Type-1 Domain containing 7A (THSD7A) associated membranous nephropathy in a female patient who was synchronously suffering from a THSD7A - positive malignancy. We here investigated the role of THSD7A as a new potential tumor antigen by evaluating over 20 000 tissue spots in more than 70 different tumor entities by immunohistochemistry using tissue microarrays. THSD7A expression was highly variable in different neoplasias with differing staining patterns. Both gain and loss of THSD7A expression compared to expression status in non-tumor tissue were linked to tumor-specific markers in the different tumor entities and were of prognostic value. The potential role of THSD7A in tumor development and therapy needs further investigation.
28035718	0	6	THSD7A	T116,T123	C2745341
28035718	7	17	expression	T045	C1171362
28035718	21	26	human	T016	C0086418
28035718	27	33	cancer	T191	C0006826
28035718	68	110	Thrombospondin Type-1 Domain containing 7A	T116,T123	C2745341
28035718	112	118	THSD7A	T116,T123	C2745341
28035718	131	153	membranous nephropathy	T047	C4054536
28035718	159	173	female patient	T032	C0150905
28035718	182	195	synchronously	T079	C0439580
28035718	196	205	suffering	T184	C0751408
28035718	213	219	THSD7A	T116,T123	C2745341
28035718	222	230	positive	T033	C1514241
28035718	231	241	malignancy	T080	C0205282
28035718	276	282	THSD7A	T116,T123	C2745341
28035718	302	315	tumor antigen	T116,T129	C0041361
28035718	342	354	tissue spots	T024	C2316370
28035718	381	395	tumor entities	T033	C1276705
28035718	399	419	immunohistochemistry	T060	C0021044
28035718	426	444	tissue microarrays	T075	C1519522
28035718	446	452	THSD7A	T116,T123	C2745341
28035718	453	463	expression	T045	C1171362
28035718	487	507	different neoplasias	T191	C0027651
28035718	523	540	staining patterns	T082	C0449778
28035718	547	560	gain and loss	T033	C0243095
28035718	564	570	THSD7A	T116,T123	C2745341
28035718	571	581	expression	T045	C1171362
28035718	594	611	expression status	T045	C1171362
28035718	615	631	non-tumor tissue	T024	C0040300
28035718	647	669	tumor-specific markers	T123	C0041365
28035718	687	701	tumor entities	T033	C1276705
28035718	714	730	prognostic value	T081	C0449821
28035718	754	760	THSD7A	T116,T123	C2745341
28035718	764	781	tumor development	T033	C1850355
28035718	786	793	therapy	T061	C4087167